Compared with SC144 treatment, SC144@HABN treatment significantly elevated the serum concentrations of HMGB-1 and CXCL-10 (p < 0.05, Fig. 2j, k) and increased CRT levels in CD45- tumor cells (p < 0.001, Fig. 2l). Here, PTPRC is linked to neoplasm.